Developing Humanized Animal Models with Transplantable Human iPSC-Derived Cells
Establishing reliable and reproducible animal models for disease modelling, drug screening and the understanding of disease susceptibility and pathogenesis is critical. However, traditional animal models differ significantly from humans in terms of physiology, immune response, and pathogenesis. As a...
Main Authors: | Min Ma, Jian-Yun Ge, Yun-Zhong Nie, Yu-Mei Li, Yun-Wen Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2024-01-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/29/1/10.31083/j.fbl2901034 |
Similar Items
-
Ethical Issues of Transplanting Organs from Transgenic Animals into Human Beings
by: Shima Behnam Manesh, et al.
Published: (2014-04-01) -
Neurexin dysfunction in neurodevelopmental and neuropsychiatric disorders: a PRIMSA-based systematic review through iPSC and animal models
by: Dan Shan, et al.
Published: (2024-02-01) -
iPSC-derived cells for whole liver bioengineering
by: Kayque Alves Telles-Silva, et al.
Published: (2024-02-01) -
Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity
by: Charlotte Flahou, et al.
Published: (2021-04-01) -
Modeling Human Cytomegalovirus-Induced Microcephaly in Human iPSC-Derived Brain Organoids
by: Guoqiang Sun, et al.
Published: (2020-04-01)